Work

Initial Clinical Sensitivity and Acquired Resistance to MET Inhibition in MET-Mutated Papillary Renal Cell Carcinoma

Year: 2013

Type: article

Source: Journal of Clinical Oncology

DOI: 10.1200/jco.2012.46.4289

Authors: Jennifer R. Diamond, Ravi Salgia, Marileila Varella-Garcia, Rajani Kanteti, Patricia M. LoRusso, Jeffrey W. Clark, Ling-Guo Xu, Keith Wilner, S. Gail Eckhardt, Keith A. Ching, Maruja E. Lira, Eric F.P.M. Schoenmakers, James G. Christensen, D. Ross Camidge

Institutions: University of Colorado Cancer Center, University of Chicago, The Barbara Ann Karmanos Cancer Institute, Massachusetts General Hospital, Pfizer (United States)

Language: English

Topic: Renal cell carcinoma treatment

Subfield: Pulmonary and Respiratory Medicine

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: green

Funders: National Institutes of Health, National Cancer Institute

Awards: G1129403178, The Development of Novel Individualized Therapy for Triple-Negative Breast Cancer, G164965655, G3646685828, G4747010862, Studies of a Novel Therapeutic Target in Non-Small Cell Lung Cancer (NSCLC), G6822452154, University of Colorado Cancer Center Support Grant

OpenAlex ID: W2145861880

FWCI: 2.918

Cites: 24

Cited by: 30

Related to: 10